Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29051017 | 0.90 | L3MBTL1 (0.38) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL10140398 | 0.81 | L3MBTL1 (0.42) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL15406173 | 0.81 | L3MBTL1 (0.42) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL29051005 | 0.81 | ACE (0.41) | L3MBTL1KMT2ACTSK | |
| SCHEMBL14777936 | 0.76 | L3MBTL1 (0.39) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL14777935 | 0.76 | L3MBTL1 (0.39) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL14788878 | 0.72 | L3MBTL1 (0.38) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL14788871 | 0.72 | L3MBTL1 (0.38) | L3MBTL1KMT2APOLBCYP1A2CYP2C9 | |
| SCHEMBL15429400 | 0.71 | HDAC6 (0.35) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL29051031 | 0.71 | CACNA1B (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116600830-A | Conjugated TLR7 and NOD2 agonists | 卢布尔雅那大学 | 2023-08-15 | — | — | CN | disclosed |